Deadline for abstracts submission:
May 1st
Deadline for FEBS YTF AWARD application:
March 26th
Time | Session/Lecture info |
---|---|
08:30-09:00 | Registration & Coffee
|
09:00-09:15 | Opening remarks
|
09:00-09:15 |
Antoine Dufour
Irit Sagi |
09:15-09:30 | Welcome talk
Chair: Prof. Israel Pecht |
09:30-11:55 | Session 1 - Interplay of proteases and matrix biology
Chair: Taina Pihlajaniemi |
09:30-10:10 |
Ulrich auf dem Keller, DTU - Technical University of Denmark
Protease network degradomics in repair and regeneration
|
10:10-10:40 |
Wee Yong, University of Calgary
The extracellular matrix in CNS lesions as an impediment to neuroregeneration
|
10:40-11:10 |
Coffee Break
|
11:10-11:40 |
Galia Blum, The Hebrew University of Jerusalem
Chemical Tools to Detect and Inhibit Protease Activity for Disease Management
|
11:40-11:55 |
Dror Chorev, Weizmann Institute of Science
A mass-spectrometry based platform for membrane embedded protease interactome and drug discovery
|
11:55-13:00 | Lunch
|
13:00-15:15 | Session 2 - From basic biochemical principles to tissue morphogenesis and homeostasis in diseases
Chair: Ulrich auf dem Keller |
13:00-13:30 |
Chen Varol , Tel-Aviv Sourasky Medical Center
Macrophages are both builders and destroyers of collagenous matrix
|
13:30-14:00 |
Roman Krawetz , University of Calgary
Post translational modifications of proteoglycsn 4 impact tissue homeostasis
|
14:00-14:30 |
Benjamin Geiger, Weizmann Institute of Science
Mechano-biological regulation of invadopodia in cancer cells
|
14:30-14:45 |
Rita Caracuel, Genyo
Unveiling new ECM immunomodulatory actions within the tumor microenvrionment: the axis ADAMTS1/Nidogen 1
|
14:45-15:15 |
Coffee Break
|
15:15-16:45 | Session 3 - Biological mechanisms of proteases and the matrix: their implications in disease
Chair: Antoine Dufour |
15:15-15:45 |
Xavier Gomis Ruth , IBMB Barcelona
Molecular analysis of a new potential glutenase for the treament of coeliac disease.
|
15:45-16:15 |
Elisabeth Nystroem, University of Calgary
Interplay between Cat-S and CLCA1 in intestinal mucus
|
16:15-16:30 |
Shay-Lee Aharoni Lotati, Weizmann Institute of Science
Designing Next Generation Substrate-Specific Protease Inhibitors
|
16:30-16:45 |
Anjana Shenoy Katapadi, Weizmann Institute of Science
Novel MMP-7 substrates in pancreatic cancer
|
16:45-17:30 | Poster session/ Discussion groups
|